WallStreetZenWallStreetZen

NASDAQ: ARGX
Argenx Se Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ARGX

Based on 12 analysts offering 12 month price targets for Argenx Se

Min Forecast
$680.00-3.97%
Avg Forecast
$789.42+11.49%
Max Forecast
$1,070.00+51.11%

Should I buy or sell ARGX stock?

Based on 12 analysts offering ratings for Argenx Se.

Strong Buy
Strong Buy
6 analysts 50%
Buy
6 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ARGX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ARGX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their ARGX stock forecasts and price targets.

ARGX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-26Find Out Why
lockedlocked$00.00+00.00%2025-08-25
lockedlocked$00.00+00.00%2025-08-04
lockedlocked$00.00+00.00%2025-08-01Find Out Why
lockedlocked$00.00+00.00%2025-08-01
HC Wainwright & Co.
Bottom 8%
8
BuyMaintains$774.00+9.31%2025-08-01
Wells Fargo
Top 3%
98
Strong BuyMaintains$756.00+6.77%2025-07-31Find out why
Wedbush
Top 8%
93
BuyReiterates$715.00+0.98%2025-06-24
Baird
Top 17%
84
BuyUpgrades$680.00-3.97%2025-05-13
Oppenheimer
Top 4%
97
BuyMaintains$708.00-0.01%2025-05-09

1 of 2

Forecast return on equity

Is ARGX forecast to generate an efficient return?

Company
35.88%
Industry
122.74%
Market
-47.8%
ARGX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ARGX forecast to generate an efficient return on assets?

Company
30.48%
Industry
46.26%
ARGX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ARGX earnings per share forecast

What is ARGX's earnings per share in the next 3 years based on estimates from 12 analysts?

Avg 1 year Forecast
$16.04-35.9%
Avg 2 year Forecast
$23.44-6.31%
Avg 3 year Forecast
$31.25+24.87%
ARGX's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ARGX revenue forecast

What is ARGX's revenue in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
$4.0B+206,796.89%
Avg 2 year Forecast
$5.1B+266,078.34%
Avg 3 year Forecast
$6.2B+324,407.64%
ARGX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ARGX earnings growth forecast

How is ARGX forecast to perform vs Biotechnology companies and vs the US market?

Company
7.58%
Industry
5.32%
Market
15.39%
ARGX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ARGX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ARGX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ARGX revenue growth forecast

How is ARGX forecast to perform vs Biotechnology companies and vs the US market?

Company
1,380.78%
Industry
82.98%
Market
10.98%
ARGX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ARGX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ARGX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ARGX$708.09$789.42+11.49%Strong Buy
ONC$308.91$335.78+8.70%Strong Buy
ALNY$451.20$422.91-6.27%Strong Buy
BNTX$104.79$138.84+32.50%Strong Buy
REGN$587.65$714.67+21.61%Buy
View Top Biotech Stocks

Argenx Se Stock Forecast FAQ

Is Argenx Se Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 12 Wall Street analysts covering (NASDAQ: ARGX) stock is to Strong Buy ARGX stock.

Out of 12 analysts, 6 (50%) are recommending ARGX as a Strong Buy, 6 (50%) are recommending ARGX as a Buy, 0 (0%) are recommending ARGX as a Hold, 0 (0%) are recommending ARGX as a Sell, and 0 (0%) are recommending ARGX as a Strong Sell.

If you're new to stock investing, here's how to buy Argenx Se stock.

What is ARGX's earnings growth forecast for 2025-2027?

(NASDAQ: ARGX) Argenx Se's forecast annual earnings growth rate of 7.58% is forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.32%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.39%.

Argenx Se's earnings in 2025 is $1,506,350,588.On average, 12 Wall Street analysts forecast ARGX's earnings for 2025 to be $979,037,427, with the lowest ARGX earnings forecast at $765,979,235, and the highest ARGX earnings forecast at $1,227,397,802. On average, 13 Wall Street analysts forecast ARGX's earnings for 2026 to be $1,430,922,452, with the lowest ARGX earnings forecast at $908,188,926, and the highest ARGX earnings forecast at $2,126,431,598.

In 2027, ARGX is forecast to generate $1,907,117,400 in earnings, with the lowest earnings forecast at $957,626,629 and the highest earnings forecast at $2,704,425,491.

What is ARGX's revenue growth forecast for 2025-2027?

(NASDAQ: ARGX) Argenx Se's forecast annual revenue growth rate of 1,380.78% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 82.98%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.98%.

Argenx Se's revenue in 2025 is $1,917,647.On average, 11 Wall Street analysts forecast ARGX's revenue for 2025 to be $242,156,370,214, with the lowest ARGX revenue forecast at $219,466,783,552, and the highest ARGX revenue forecast at $260,408,526,253. On average, 11 Wall Street analysts forecast ARGX's revenue for 2026 to be $311,540,600,355, with the lowest ARGX revenue forecast at $285,898,240,034, and the highest ARGX revenue forecast at $348,114,674,527.

In 2027, ARGX is forecast to generate $379,810,407,002 in revenue, with the lowest revenue forecast at $351,276,246,191 and the highest revenue forecast at $407,043,196,558.

What is ARGX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ARGX) forecast ROA is 30.48%, which is lower than the forecast US Biotechnology industry average of 46.26%.

What is ARGX's Price Target?

According to 12 Wall Street analysts that have issued a 1 year ARGX price target, the average ARGX price target is $789.42, with the highest ARGX stock price forecast at $1,070.00 and the lowest ARGX stock price forecast at $680.00.

On average, Wall Street analysts predict that Argenx Se's share price could reach $789.42 by Aug 26, 2026. The average Argenx Se stock price prediction forecasts a potential upside of 11.49% from the current ARGX share price of $708.09.

What is ARGX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ARGX) Argenx Se's current Earnings Per Share (EPS) is $25.02. On average, analysts forecast that ARGX's EPS will be $16.04 for 2025, with the lowest EPS forecast at $12.55, and the highest EPS forecast at $20.11. On average, analysts forecast that ARGX's EPS will be $23.44 for 2026, with the lowest EPS forecast at $14.88, and the highest EPS forecast at $34.84. In 2027, ARGX's EPS is forecast to hit $31.25 (min: $15.69, max: $44.31).

What is ARGX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ARGX) forecast ROE is 35.88%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.